| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |